Diagnostic Workup and Treatment for Suspected Dementia in Patients Over 65
For a patient over 65 with suspected dementia, begin with a structured two-visit approach: first visit includes validated cognitive screening (Mini-Cog or verbal fluency test), comprehensive history from both patient and informant documenting functional decline, dementia-focused neurologic exam, and ordering of basic labs plus brain imaging; second visit includes detailed cognitive testing (MMSE, clock drawing, Geriatric Depression Scale) and integration of all findings to establish diagnosis and initiate treatment. 1
Initial Evaluation (Visit 1)
History Taking - Critical Elements
Obtain history from both the patient AND a knowledgeable informant (family member or close friend) focusing on:
- Specific cognitive domains affected: memory (especially recent events), language difficulties, attention problems, visuospatial issues (getting lost), executive dysfunction (planning, judgment)
- Functional impact on daily activities: managing finances, medications, driving, cooking, shopping
- Timeline and progression: gradual onset over months-years suggests Alzheimer's disease; rapid progression over weeks-months is a red flag requiring urgent specialist referral
- Risk factor profile: cardiovascular disease, stroke history, family history of dementia, educational level, medications (especially anticholinergics), alcohol use, sleep disorders 1, 2
Critical pitfall: Never rely solely on patient self-report—cognitive impairment often impairs insight. Informant history is essential for accurate diagnosis 1.
Cognitive Screening - Use Validated Tools
Administer a brief validated screening instrument (can be completed in 60-90 seconds):
- Mini-Cognitive Assessment Instrument (Mini-Cog): 3-item recall plus clock drawing
- Verbal fluency test: name as many animals as possible in 60 seconds (normal >15)
- These have high sensitivity/specificity and are time-efficient for primary care 3, 4
Do not interpret cognitive test scores in isolation—integrate with risk profile, functional history, and examination findings 1.
Physical and Neurologic Examination
Perform a dementia-focused neurologic exam looking for:
- Focal neurologic signs: weakness, sensory loss, visual field defects (suggests stroke/vascular dementia)
- Movement abnormalities: tremor, rigidity, bradykinesia (suggests Lewy body dementia or Parkinson's disease dementia)
- Gait disturbances: shuffling, instability, magnetic gait (vascular dementia, normal pressure hydrocephalus)
- Primitive reflexes: grasp, snout reflexes (frontal lobe dysfunction)
- Signs of delirium: fluctuating attention, acute confusion (requires urgent evaluation) 1
Laboratory Testing - Core Panel
Order the following basic laboratory tests to identify reversible causes:
- Complete blood count (anemia, infection)
- Comprehensive metabolic panel (renal/hepatic dysfunction, electrolyte abnormalities)
- Thyroid-stimulating hormone (hypothyroidism)
- Vitamin B12 level (deficiency)
- Consider: syphilis serology, HIV testing (in appropriate risk populations) 2, 4
Brain Imaging - When to Order
Obtain structural brain imaging (CT or MRI) in selected cases:
- Focal neurologic signs on examination
- Rapid or atypical progression
- Age <65 years (early-onset dementia)
- History of significant head trauma
- Unexplained neurologic symptoms
- Anticoagulation use or bleeding disorder
- To rule in cerebrovascular disease or rule out structural lesions (tumor, subdural hematoma, normal pressure hydrocephalus) 2, 4
MRI is preferred over CT when available—better visualization of vascular changes, hippocampal atrophy, and subtle structural abnormalities 4.
Second Visit - Detailed Assessment
Comprehensive Cognitive Testing
If screening was abnormal or clinical suspicion remains high:
- Mini-Mental State Examination (MMSE): 30-point test covering multiple cognitive domains
- Clock drawing test: assesses visuospatial and executive function
- Geriatric Depression Scale: depression can mimic or coexist with dementia
- Additional verbal fluency testing if not completed at first visit 3
When Neuropsychological Testing Is Needed
Refer for formal neuropsychological evaluation when:
- Patient/caregiver report concerning symptoms BUT office cognitive testing is normal (high-functioning individuals may compensate)
- Abnormal cognitive testing BUT uncertainty about interpretation due to:
- Very high or very low educational attainment
- Language/cultural factors
- Complex psychiatric history
- Need to differentiate mild cognitive impairment from early dementia [1, @14@]
Red Flags Requiring Urgent Specialist Referral
Immediately refer to dementia specialist if any of the following:
- Rapidly progressive dementia (weeks to months): broad differential including prion disease, autoimmune encephalitis, CNS infection, paraneoplastic syndromes—requires urgent workup 1
- Delirium features: fluctuating attention, acute onset—medical emergency requiring same-day evaluation 1
- Early-onset dementia (age <65): different differential diagnosis, often genetic causes, requires specialized testing 1
- Atypical presentations:
Treatment Approach
Non-Pharmacologic Interventions - First Line
All patients should receive counseling on:
- Cognitively engaging activities: reading, puzzles, learning new skills
- Regular physical exercise: walking 30 minutes daily, aerobic activity
- Social engagement: family gatherings, community activities, support groups
- Vascular risk factor management: blood pressure control, diabetes management, smoking cessation
- Sleep optimization: treat obstructive sleep apnea if present
- Medication review: discontinue anticholinergics and other cognitive-impairing drugs 2, 6
Pharmacologic Treatment for Alzheimer's Disease
For mild to moderate Alzheimer's disease:
- Start cholinesterase inhibitor: donepezil 5mg daily, increase to 10mg after 4-6 weeks
- Alternative agents: rivastigmine (patch formulation preferred to reduce GI side effects) or galantamine
- Monitor for efficacy at 3-6 months; discontinue if no benefit or intolerable side effects 2, 7
For moderate to severe Alzheimer's disease:
- Add memantine 5mg daily, titrate to 10mg twice daily (or 28mg extended-release daily)
- Can be used alone or combined with cholinesterase inhibitor
- Note: Recent guidelines suggest NOT routinely combining memantine with cholinesterase inhibitors due to limited additional benefit 7
For Parkinson's disease dementia:
- Rivastigmine is specifically indicated (oral or patch formulation) 2
Managing Behavioral and Psychological Symptoms
For agitation/aggression:
- First: exhaust all non-pharmacological approaches (environmental modification, caregiver education, addressing pain/discomfort)
- If severe or risk of harm: consider atypical antipsychotics (risperidone, quetiapine) at lowest effective dose
- Critical: regularly reassess need and discontinue when symptoms resolve—increased stroke and mortality risk 6, 8
For depression in dementia:
- Citalopram has evidence for agitation in Alzheimer's disease
- Standard antidepressants for comorbid major depression 8
For psychosis in Alzheimer's disease:
- Pimavanserin has demonstrated efficacy specifically for psychosis in Alzheimer's patients 8
Ongoing Management
Establish regular follow-up schedule:
- Every 3-6 months minimum in primary care
- Monitor cognitive trajectory, functional status, caregiver burden
- Reassess medication efficacy and side effects
- Update advance care planning and safety assessments (driving, wandering, financial exploitation)
- Provide caregiver support and resources 6
Key pitfall: Dementia is often multifactorial—most patients have Alzheimer's pathology PLUS cerebrovascular disease. Address all modifiable vascular risk factors aggressively 2, 6.